Abstract
Intracerebroventricular injection of 6-hydroxydopamine (6-OH-DA) prevented the development of the lypressin (LVP)-induced hypertension. Administration of 6-OH-DA to hypertensive rats significantly decreased, but did not normalize, blood pressure. A fourteen-day treatment with clonidine, guanethidine, reserpine, dihydralazine, propranolol and furosemide produced a transient decrease in blood pressure in LVP-hypertensive rats. Eight weeks after the withdrawal of hypotensive drugs blood pressure again reached the value corresponding to that in untreated LVP-hypertensive rats.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antihypertensive Agents / pharmacology*
-
Brain / drug effects
-
Brain / metabolism
-
Cerebral Ventricles / drug effects
-
Cerebral Ventricles / physiology
-
Hydralazine / pharmacology
-
Hydroxydopamines / administration & dosage
-
Hydroxydopamines / pharmacology*
-
Hypertension / chemically induced
-
Hypertension / physiopathology*
-
Injections, Intraventricular
-
Lypressin
-
Male
-
Norepinephrine / metabolism
-
Oxidopamine
-
Propranolol / pharmacology
-
Rats
-
Rats, Inbred Strains
-
Reserpine / pharmacology
Substances
-
Antihypertensive Agents
-
Hydroxydopamines
-
Hydralazine
-
Lypressin
-
Reserpine
-
Oxidopamine
-
Propranolol
-
Norepinephrine